Retinol binding protein 4 (RBP4) concentration identifies V122I transthyretin cardiac amyloidosis

Marios ArvanitisDepartment of Medicine, Boston University School of Medicine, Boston Medical Center, Boston, MA, USA,

Steven SimonDepartment of Medicine, Boston University School of Medicine, Boston Medical Center, Boston, MA, USA,

Gloria ChanAmyloidosis Center, Boston University School of Medicine, Boston Medical Center, Boston, MA, USA,

Denise FineSection of Cardiovascular Medicine, Boston University School of Medicine, Boston Medical Center, Boston, MA, USA,

Paula BeardsleySection of Cardiovascular Medicine, Boston University School of Medicine, Boston Medical Center, Boston, MA, USA,

Michael LaValleyDepartment of Biostatistics, Boston University School of Public Health, Boston, MA, USA,

Daniel JacobsonAmyloidosis Center, Boston University School of Medicine, Boston Medical Center, Boston, MA, USA, ;Division of Hematology/Oncology, Department of Medicine, VA Boston Healthcare System, Boston, MA, US, and

Clarissa KochAmyloidosis Center, Boston University School of Medicine, Boston Medical Center, Boston, MA, USA,

John L. BerkDepartment of Medicine, Boston University School of Medicine, Boston Medical Center, Boston, MA, USA, ;Amyloidosis Center, Boston University School of Medicine, Boston Medical Center, Boston, MA, USA,

Lawreen H. ConnorsAmyloidosis Center, Boston University School of Medicine, Boston Medical Center, Boston, MA, USA, ;Department of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston Medical Center, Boston, MA, USA

Frederick L. RubergAmyloidosis Center, Boston University School of Medicine, Boston Medical Center, Boston, MA, USA, ;Section of Cardiovascular Medicine, Boston University School of Medicine, Boston Medical Center, Boston, MA, USA, Correspondence[email protected]

show all

"Retinol binding protein 4 (RBP4) concentration identifies V122I transthyretin cardiac amyloidosis." Amyloid, 24(sup1), pp. 120–121

Declaration of interest

The study was supported by NIH R21AG050206, R01AG031804, 1UL1TR001430 grants and by the Young Family Amyloid Research Fund. The authors report no conflicts of interest.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Retinol binding protein 4 (RBP4) concentration identifies V122I transthyretin cardiac amyloidosis

Information for

Open access

Opportunities

Help and information

Retinol binding protein 4 (RBP4) concentration identifies V122I transthyretin cardiac amyloidosis

Declaration of interest

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature